Skip to main content
An official website of the United States government

Supportive Care and Symptom Management

The Supportive Care and Symptom Management program supports studies on the prevention or treatment of acute and chronic symptoms and morbidities related to cancer and its treatment. This includes the impact on the quality of life of patients and their informal caregivers. The program also supports studies of patients and their caregivers at the end of life.

On This Page

  • All Heading 2s will automatically be pulled in to this list.
  • Do not edit the content on this template.

About Supportive Care and Symptom Management

The program supports research in three areas: prevention or treatment of acute or chronic symptoms and morbidities related to cancer, its treatment and caregiving (symptom management research); effects on quality of life from cancer, its treatment and caregiving (quality of life research); and end-of-life psychosocial issues, caregiving and treatment strategies (end-of-life research).

Through the NCI Community Oncology Research Program (NCORP), clinical trials are underway to evaluate therapies to prevent or ameliorate a broad range of symptoms and/or toxicities associated with cancer its treatment and caregiving. Other studies funded separately are investigating a range of treatment effects on health-related quality of life and a variety of influences on the end-of-life cancer experience. 

Topic Areas include: Anorexia, Cachexia, Cardiotoxicity, Caregiver Issues, Cognitive Dysfunction, Distress/Anxiety/Depression, End of Life, Fatigue, Geriatrics, Hot Flashes, Lymphedema, Medication Adherence, Mucositis, Multiple Symptoms, Musculoskeletal Symptoms, Nausea, Neuropathy, Nutrition, Oral Complications, Other Supportive Care Issues, Pain, Palliative Care, Pediatrics/Adolescents/Young Adult, Physical Functioning, Quality of Life, Skin Toxicities, Sleep Disorders, and Urinary Complications.

Selected Topics

Funding Opportunities

No matching Funding Opportunities were found.

View All Funding Opportunities

Grantee Details

PI Name Sort descending PI Organization Title Grant Number Program Official
Vijayvergia, Namrata

Research Inst Of Fox Chase Can Ctr
United States

Exploring the Neuroprotective Potential of CBD in Preventing Oxaliplatin-Induced Neuropathy: A Prospective Study 1R21CA292276-01A1 Rachel Altshuler, Ph.D.
Vijayvergia, Namrata

Research Inst Of Fox Chase Can Ctr
United States

Exploring the Neuroprotective Potential of CBD in Preventing Oxaliplatin-Induced Neuropathy: A Prospective Study 1R21CA292276-01A1 Rachel Altshuler, Ph.D.
Villanueva, Augusto

Icahn School Of Medicine At Mount Sinai
United States

Liquid biopsy and radiomics for liver cancer surveillance 4U01CA283931-03 Sidney Fu, M.D.
Vinciguerra, Vincent P

Feinstein Institute For Medical Research
United States

Northwell Health NCORP 3UG1CA189850-11S2 Vanessa A. White, M.P.H.
Vinciguerra, Vincent P

Feinstein Institute For Medical Research
United States

Northwell Health NCORP 3UG1CA189850-11S2 Vanessa A. White, M.P.H.
Wagner, Lynne I.

Ecog-Acrin Medical Research Foundation
United States

ECOG-ACRIN NCORP Research Base 3UG1CA189828-11S2 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Wagner, Lynne I.

Ecog-Acrin Medical Research Foundation
United States

ECOG-ACRIN NCORP Research Base 3UG1CA189828-11S2 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Wallace, Douglas C

Children'S Hosp Of Philadelphia
United States

Anti-tumor immunity and intestinal microbiota are modulated by mitochondrial DNA 5R01CA259635-04 Young Kim, Ph.D.
Wang, Hsiao-Lan

University Of Alabama At Birmingham
United States

A Motion Exergaming Approach to Promote Self-Managing Fatigue and Pain after Head and Neck Cancer Treatment 5R01CA244947-06 Goli Samimi, Ph.D., M.P.H.
Wang, Kai

Massachusetts General Hospital
United States

Dietary prevention for colorectal cancer: targeting the bile acid/gut microbiome axis 4R00CA283146-03 Amit Kumar, Ph.D.
Wang, Linghua

University Of Tx Md Anderson Can Ctr
United States

Center for Gastric Pre-Cancer Atlas of Multidimensional Evolution in 3D (GAME3D) 4U01CA294518-02 Indu Kohaar, Ph.D., M.Phil., M.Sc.
Wang, Hsiao-Lan

University Of Alabama At Birmingham
United States

A Motion Exergaming Approach to Promote Self-Managing Fatigue and Pain after Head and Neck Cancer Treatment 5R01CA244947-06 Goli Samimi, Ph.D., M.P.H.
Wang, Thomas D

University Of Michigan At Ann Arbor
United States

Peptide multimer for early detection of hepatocellular carcinoma 5R01CA285303-02 Guillermo Marquez, Ph.D.
Wang, Tza-Huei Jeff

Johns Hopkins University
United States

A low-cost, multiplexed digital high resolution melt platform for DNA methylation-based detection and identification of cancers in liquid biopsies 5R33CA272321-03 Christos Patriotis, Ph.D., M.Sc.
Wang, Tza-Huei Jeff

Johns Hopkins University
United States

Development of a low-cost epigenetic screening assay for Pap specimen-based detection of early-stage ovarian cancer in high-risk women 5R01CA260628-05 Christos Patriotis, Ph.D., M.Sc.

Clinical Trials

Status

No matching Clinical Trials were found.

View All Clinical Trials